scispace - formally typeset
Y

Yutaka Suzuki

Researcher at University of Tokyo

Publications -  875
Citations -  42146

Yutaka Suzuki is an academic researcher from University of Tokyo. The author has contributed to research in topics: Gene & Medicine. The author has an hindex of 85, co-authored 767 publications receiving 35471 citations. Previous affiliations of Yutaka Suzuki include Japan Agency for Medical Research and Development & Institute for the Physics and Mathematics of the Universe.

Papers
More filters
Journal ArticleDOI

Extremely slow rate of evolution in the HOX cluster revealed by comparison between Tanzanian and Indonesian coelacanths

TL;DR: The present study implies that the reduction of the nucleotide substitution rate in coelacanth HOX genes may account for the conservation of coelacanths morphology during evolution.
Journal ArticleDOI

Hunting the subset-specific genes of neuroblastoma: expression profiling and differential screening of the full-length-enriched oligo-capping cDNA libraries.

TL;DR: To understand the molecular mechanism of NBL's genesis and biology as well as that of the neural crest development, full-length-enriched cDNA libraries are constructed by an oligo-capping method from two different subsets of primary NBL, one with favorable biology and the other with MYCN amplification.
Journal ArticleDOI

Transcriptome Analyses of Human Genes and Applications for Proteome Analyses

TL;DR: Rapidly accumulating genome data as well as versatile use of the transcriptome information will shortly lay a firm foundation for proteome-level understanding of human gene networks.
Journal ArticleDOI

The promoter structure of TGF-beta type II receptor revealed by "oligo-capping" method and deletion analysis.

TL;DR: The promoter of TGF-beta type II receptor lacks TATA box or CAAT box and contains two adjacently located promoters (P1 and P2) capable of acting by itself.
Journal ArticleDOI

Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer

TL;DR: In this article, the authors investigated the role of regional LNs in colorectal cancer immunotherapy and found that LNs comprised an intermediate level of the effector T cell population between peripheral blood lymphocytes (PBLs) and TILs.